IE33207L - Pharmaceutical compositions containing diazacarbazole - Google Patents

Pharmaceutical compositions containing diazacarbazole

Info

Publication number
IE33207L
IE33207L IE42969A IE42969A IE33207L IE 33207 L IE33207 L IE 33207L IE 42969 A IE42969 A IE 42969A IE 42969 A IE42969 A IE 42969A IE 33207 L IE33207 L IE 33207L
Authority
IE
Ireland
Prior art keywords
diazacarbazole
pharmaceutical compositions
compositions containing
march
antiviral
Prior art date
Application number
IE42969A
Other versions
IE33207B1 (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE33207L publication Critical patent/IE33207L/en
Publication of IE33207B1 publication Critical patent/IE33207B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,262,864. Antiviral compositions. GLAXO LABORATORIES Ltd. 25 March, 1969 [29 March, 1968], No. 15328/68. Heading A5B. [Also in Division C2] Therapeutic compositions for oral, topical, rectal intravaginal or parenteral administration contain as antiviral agent a 1, 3- or 1, 8-diazacarbazole (or their physiologically acceptable salts), together with a carrier, excipient and/or further medicinal agent; the latter may be a steroid such as betamethasone-21-phosphate or an antibiotic such as tetracycline. [GB1262864A]
IE42969A 1968-03-29 1969-03-28 Diazacarbazoles IE33207B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1532868A GB1262864A (en) 1968-03-29 1968-03-29 Diazacarbazoles

Publications (2)

Publication Number Publication Date
IE33207L true IE33207L (en) 1969-09-29
IE33207B1 IE33207B1 (en) 1974-04-17

Family

ID=10057154

Family Applications (1)

Application Number Title Priority Date Filing Date
IE42969A IE33207B1 (en) 1968-03-29 1969-03-28 Diazacarbazoles

Country Status (6)

Country Link
CH (1) CH549039A (en)
DE (1) DE1916011A1 (en)
FR (1) FR2005118A1 (en)
GB (1) GB1262864A (en)
IE (1) IE33207B1 (en)
NL (1) NL6904815A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2019812C (en) * 1989-06-28 2000-11-21 Gunther Schmidt (Deceased) Novel 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of aids
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
NZ627188A (en) * 2012-01-27 2015-12-24 Univ Montreal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
WO2014145576A2 (en) 2013-03-15 2014-09-18 Northwestern University Substituted pyrrolo(2,3-d)pyrimidines for the treatment of cancer
CN110156792A (en) * 2019-06-28 2019-08-23 广州暨南生物医药研究开发基地有限公司 A kind of pyrimido benzazolyl compounds and its preparation method and application

Also Published As

Publication number Publication date
NL6904815A (en) 1969-10-01
GB1262864A (en) 1972-02-09
FR2005118A1 (en) 1969-12-05
IE33207B1 (en) 1974-04-17
CH549039A (en) 1974-05-15
DE1916011A1 (en) 1970-03-05

Similar Documents

Publication Publication Date Title
ES368496A1 (en) Aqueous doxycycline compositions
IL34713A (en) Anaesthetic pharmaceutical preparations containing 3alpha-hydroxy-5alpha-pregnane 11,20-dione
IE33207L (en) Pharmaceutical compositions containing diazacarbazole
GB1202148A (en) Pharmaceutical compositions
GB1268771A (en) Azacarbazoles
ES368325A1 (en) Cephalosporius having a thioltherified methyl group in the 3-position
GB1270049A (en) New pharmaceutical product
GB1216295A (en) New enzyme inhibitors and their preparation
GB1358098A (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
ZA714785B (en) A pharmaceutical composition containing a pharmaceutically active compound
AU2440371A (en) Pharmaceutically active substituted pyrrolidines
IL39889A0 (en) Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
ES469648A1 (en) Oleandomycin derivatives
CA941375A (en) 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
GB1318533A (en) 3-2-cyanophenoxy-2-hydroxy-n-ethyl-propylamine
GB1242742A (en) Drug for stimulating the central nervous system
AU429842B2 (en) New pharmaceutically active 2, 3 benzoazine derivatives
CA858573A (en) Pharmacologically active hexahydroisoquinolino (2, 1-d) benzo (1,4) diazepine compound and salts thereof
GB1446615A (en) Pharmaceutical compositions containing an anti-allergy drug
AU4368968A (en) New pharmaceutically active 2, 3 benzoazine derivatives
AU454743B2 (en) New pharmaceutically active 1, 4 dihydropyridines
IL78801A (en) N2-naphthalene-sulfonyl-l-argininamides,the pharmaceutically acceptable salts thereof,their preparation and pharmaceutical compositions containing them
CA983928A (en) Pharmaceutically active new 1,3-aminoalcohol esters and their salts and a process for the preparation thereof
CA840458A (en) Fabrication d'alcools par oxydation d'hydrocarbures satures